Twist Bioscience Corp. Ownership
$181.69
1.16%
Nasdaq, Sep 29, 11:01 am EDT.
Market open.
Twist Bioscience Corp. Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Artisan Partners Limited Partnership
|
6.368m | 10.16% | +150.564k | Mar 31 2026 |
| 2 |
ARK Investment Management LLC
|
6.343m | 10.12% | -1.217m | Mar 31 2026 |
| 3 |
EdgePoint Investment Group Inc.
|
5.383m | 8.59% | +4.530k | Mar 31 2026 |
| 4 |
William Blair Investment Management, LLC
|
5.270m | 8.41% | -684.711k | Mar 31 2026 |
| 5 |
BlackRock Institutional Trust Company, N.A.
|
4.676m | 7.46% | -123.179k | Mar 31 2026 |
|
1
Artisan Partners Limited Partnership
|
10.16%
6.368m
|
|
2
ARK Investment Management LLC
|
10.12%
6.343m
|
|
3
EdgePoint Investment Group Inc.
|
8.59%
5.383m
|
|
4
William Blair Investment Management, LLC
|
8.41%
5.270m
|
|
5
BlackRock Institutional Trust Company, N.A.
|
7.46%
4.676m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 44.74% of Twist Bioscience Corp., with Artisan Partners Limited Partnership the biggest at 10.16%, followed by ARK Investment Management LLC (10.12%) and EdgePoint Investment Group Inc. (8.59%). |
Recent Twist Bioscience Corp. Insider Transactions
Powered by
| Date | Insider & Role | Type | Price | Quantity | Volume |
|---|---|---|---|---|---|
| Sep 29 2026 |
John Mitchell
CEO
|
Purchases
|
$182.45 | + 15,000 | $2,736,750 |
| Sep 26 2026 |
Sarah Chen
CFO
|
Sales
|
$179.80 | - 8,500 | $1,528,300 |
| Sep 22 2026 |
Robert Williams
COO
|
Purchases
|
$175.20 | + 12,000 | $2,102,400 |
| Sep 17 2026 |
Emily Rodriguez
Director
|
Sales
|
$181.30 | - 5,200 | $942,760 |
| Sep 11 2026 |
Michael Thompson
SVP Operations
|
Purchases
|
$170.50 | + 20,000 | $3,410,000 |
| Sep 04 2026 |
Lisa Park
General Counsel
|
Sales
|
$177.90 | - 6,800 | $1,209,720 |
| No transactions found for this filter. | |||||
|
John Mitchell
PURCHASES
|
Sep 29 2026
$182.45
|
|
Sarah Chen
SALES
|
Sep 26 2026
$179.80
|
|
Robert Williams
PURCHASES
|
Sep 22 2026
$175.20
|
|
Emily Rodriguez
SALES
|
Sep 17 2026
$181.30
|
|
Michael Thompson
PURCHASES
|
Sep 11 2026
$170.50
|
|
Lisa Park
SALES
|
Sep 04 2026
$177.90
|
| No transactions found for this filter. | |
| Insider transactions show you what executives, directors and major shareholders do with their own stock: people who know the company from the inside. Buys are the most telling signal, because insiders invest their own money. Sells are harder to read, since they can also be driven by taxes, diversification or expiring option programs. |
Twist Bioscience Corp. Short interest
Powered by
| Short interest shows what share of a stock's freely tradable shares (float) is currently sold short, meaning held by investors betting on falling prices. A high or rising level can be read two ways: it reflects the skepticism of many market participants, but also carries upside potential. Because if the stock rises, short sellers have to buy back, which can push the price up even further. This effect is called a short squeeze. | |
| The short interest in Twist Bioscience Corp. has held steady at around 23.8% of the float over the past 12 months. Short sellers' positioning has barely changed in this period. |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
